# Architecture Review — Round 7: CTO / CEO / Executive

| Field | Value |
|---|---|
| **Round** | 7 of N |
| **Reviewer lens** | Executive (CTO / CEO) — strategic value alignment, risk concentration, commercial implications, partnership economics, vendor strategy, decision authority, board-level concerns, ROI, success metrics, business continuity |
| **Documents** | `docs/BUSINESS_REQUIREMENTS.md` (BRD), `docs/ARCHITECTURE_REQUIREMENTS.md` (ARD) |
| **Date** | 2026-04-29 |
| **Prior rounds** | `docs/reviews/01-principal-architect.md` through `docs/reviews/06-principal-uiux.md` |

The user directed: *"Be sure to revisit the business rules! Do NOT create any missing business documents, those are in another repository. This is a technical repository and should be left as such. The business rules are the real expression of business concerns and the other two documents are expressions of those."*

That framing is correct and shapes this review:
1. The BRD is the **technical expression of business concerns**. Strategic documents (PRD, strategy memos, board materials) live elsewhere.
2. This review **stays in the technical repo**. It does not propose creating strategy documents here.
3. This review **revisits business rules** with executive eyes — asking whether each rule is calibrated to actual business value, surfaces strategic tradeoffs cleanly, and connects to upstream strategic documents.

The executive lens asks questions that engineering, security, compliance, ops, and UX cannot ask alone:
- Why does this platform exist (vs. buying it, partnering, or doing nothing)?
- What competitive advantage does it create (vs. table stakes)?
- What's the 3-year cost vs. value? Risk-adjusted ROI per phase?
- Who owns what decisions? Where does escalation go?
- What's the board-level risk surface?
- How does this enable or constrain future strategic moves (M&A, expansion, divestiture)?
- Is the engineering team structured to deliver this?

Severity per Constitution Rule 29 (BLOCKER / FINDING / ADVISORY).

---

## TL;DR

**Will the platform be valuable if we proceed as-is? Likely yes for v1; the strategic gaps below determine whether it's valuable at v3 and beyond.**

The BRD/ARD do well at the technical expression of business rules. They poorly express the *strategic context* in which those rules sit. Specifically:

1. **Business rules don't connect to business value.** Each BR has rationale and enforcement; none have business-value statements (why this rule, what business outcome, what's the cost of NOT having this rule). This makes engineering prioritization a guess and makes ruthless deferral impossible.
2. **No decision authority is visible.** Who approved the seven-context decomposition? The Sequelae PH boundary? The single-region commitment? The 4-tier match policy? Without explicit authority, every future amendment has unclear approval.
3. **The strategic context is implicit.** The BRD references PROBLEM_BRIEF, TECH_STACK, RESEARCH_NOTES — fine for the technical scope but doesn't connect to corporate strategy, OKRs, board-approved roadmap. Executives reviewing this artifact cannot tell whether the platform serves Lore's strategic intent or whether engineering chose its own path.
4. **No business success metrics.** "Phase exit criteria" are technical. Verification API at p95 ≤ 200ms is engineering. None of: members onboarded per quarter, partner contracts retained, member NPS, eligibility data quality score, attestation maintenance cost, total cost of ownership trajectory, revenue impact, customer acquisition cost contribution.
5. **Vendor concentration is unflagged.** All-in on GCP across data, compute, KMS, audit, IAM, networking, observability. Strategic single-point-of-failure for a HIPAA-regulated platform. Worth surfacing to the board even if the answer is "we accept this."
6. **Partnership economics are unaddressed.** Each partner has its own contract; no rules differentiate strategic anchor partners from peripheral ones. Resource allocation and feature prioritization should reflect the partnership tier.
7. **Phased delivery is engineering-phased, not revenue-phased.** Phase 1 ends at "single-partner end-to-end." When does the platform start generating value (revenue, member onboarding, attestation maturity)? Implicit in the engineering phase plan; not explicit.

**66 findings: 16 BLOCKERS, 39 FINDINGS, 11 ADVISORIES.**

After consolidating across all seven rounds, the unique BLOCKER set spans approximately **95-100 items**. With the executive BLOCKERs addressed, the platform is strategically defensible — it serves Lore's intent, has clear ownership and accountability, has visible cost and value trajectories, and surfaces the right risks at the right level.

Without them, the platform may be technically excellent and operationally sound, yet strategically rudderless — built right, but possibly not the right thing built.

---

## What the Executive Lens Owns That Prior Rounds Could Not

Prior rounds had standing to identify gaps in their domain. They did not have standing to:

1. **Question whether the platform should exist at all** (build vs. buy vs. partner vs. defer).
2. **Determine strategic priority** (which BRs serve Lore's competitive position, which are table stakes, which are gold-plating).
3. **Allocate resources** (headcount, budget, time across roadmap).
4. **Set success metrics** at the business level (revenue impact, partner retention, member NPS).
5. **Approve material risks** (vendor concentration, single-region, regulatory enforcement exposure).
6. **Define decision authority** (who can change the architecture, who escalates, who approves phase transitions).
7. **Engage the board** (which findings rise to board attention, what the reporting cadence is).
8. **Connect to corporate strategy** (how this platform serves Lore's 3-year plan).
9. **Make commercial commitments** (SLAs to partners, to the Lore application team, to members).
10. **Drive M&A readiness** (data portability, integration story, divestiture posture).

This review surfaces those gaps. Most resolution requires executive engagement, not engineering work.

---

## Strengths from an Executive View

What's strategically right and should be preserved:

1. **Risk-aware default posture.** The BRD treats privacy and compliance as Priority 0. For an ACO, that's correct positioning.
2. **Phased delivery with exit criteria.** Phases are testable, not just aspirational. Phase 1 commitment to single-partner end-to-end is right-sized for early value validation.
3. **Sequelae PH boundary as architecture, not policy.** Treating cross-border data residency as architectural enforcement is a strategic decision well-executed (regardless of the technical findings in prior rounds).
4. **Build-on-managed-services bias.** Cloud Run, AlloyDB, Datastream, Cloud KMS — managed services reduce operational burden vs. self-managing. Right tradeoff for ACO scale.
5. **Modular monolith pattern.** Defensible team-size decision. Prior project reference (Conclave per Round 1 ADR-0001 references) shows learning.
6. **Configuration-driven partner onboarding (BR-802).** Lower marginal cost per new partner — good unit economics signal.
7. **Phased attestation strategy.** Phase 4 dedicated to attestation prep acknowledges that attestations gate larger partner contracts. Right sequencing.
8. **Open questions explicit.** ARD §"Open Architectural Questions" surfaces unresolved decisions; board-level visibility is then possible.

These work. Findings extend or fill gaps around them.

---

## 1. Strategic Value Alignment

The single biggest gap: business rules without business-value statements.

### E-001: Business value per rule is not stated — BLOCKER

**Where:** BRD has 70+ rules; each has rationale and enforcement. None have business-value statements.

**Why it matters:** "Rationale" answers why a rule is reasonable. "Business value" answers why this rule is *valuable* — what business outcome it produces, what's the cost of not having it, who benefits. Without business value statements:
- Engineering prioritization is a guess.
- Ruthless deferral is impossible (every rule looks equally important).
- Strategic tradeoffs are invisible (which rules are differentiation vs. table stakes).
- Audit defensibility weakens ("why did you implement this?" → "the BRD said so" is not a strategic answer).

**What's needed:** BRD addition: business-value statement per rule. Schema:
- **Business outcome served**: e.g., "Member trust" / "Partner contract retention" / "HIPAA defensibility" / "Operational efficiency" / "Revenue protection"
- **Cost of absence**: what happens if we don't have this rule
- **Strategic vs. table stakes**: is this differentiated value or ground-floor compliance

This does not require new strategic documents (the user's instruction). It requires extending each existing rule with one or two lines of business-value framing. The strategic documents elsewhere can be referenced; the BRD inherits and concentrates the technical expression.

**Effort:** M (existing rules + ongoing per amendment).

---

### E-002: Strategic tier of each rule is not designated — BLOCKER

**Where:** BRD treats all rules with similar weight. No tiering.

**Why it matters:** Some rules are differentiated competitive value (privacy-preserving collapse on Verification, deletion ledger, attribution neutrality). Some are table stakes (encrypted at rest, HIPAA Security Rule controls). Some are gold-plating (highly configurable thresholds when no partner has asked for the customization). Treating them equally costs resources misallocated.

**What's needed:** BRD addition: per-rule tier designation:
- **Strategic differentiator**: rules that create competitive advantage (rare, valuable)
- **Compliance baseline**: rules required for HIPAA / state law / contract; non-negotiable
- **Operational excellence**: rules that improve cost, reliability, scale; valuable
- **Optionality**: rules that preserve future moves (configurability, format flexibility); valuable but lower priority
- **Gold-plating**: rules that exceed any current or near-term need; defer

Example: BR-101 (tiered match decision) is **operational excellence** + partial differentiator (Tier 3 review queue is differentiated; tiers 1/2/4 are baseline). BR-704 (deletion auditability) is compliance baseline. XR-001 (layered configurability) is optionality.

**Effort:** S (one tier designation per rule).

---

### E-003: Connection to corporate strategy is implicit — BLOCKER

**Where:** BRD/ARD reference PROBLEM_BRIEF, TECH_STACK, RESEARCH_NOTES, CONTEXT. No reference to corporate strategy, OKRs, board-approved roadmap.

**Why it matters:** Per the user's instruction, strategic documents live in another repo. The technical repo should reference them, not duplicate them. Today the BRD/ARD don't reference. An executive reviewing this artifact cannot tell whether the platform serves Lore's strategic intent.

**What's needed:** BRD §"Relationship to Other Documents" addition:
- Reference to corporate strategy doc (with location in the strategy repo)
- Reference to OKR / quarterly objective doc
- Reference to board-approved roadmap
- Statement of how the platform aligns

This is documentation linkage, not document creation. Three sentences and a link list suffice.

**Effort:** S.

---

### E-004: Competitive positioning unstated — FINDING

**Where:** Not addressed.

**Why it matters:** What makes Lore's eligibility platform competitively different? Identity resolution accuracy? Partner onboarding speed? Member trust UX? Attestation maturity? Lower TCO? Without explicit positioning, every choice is in a vacuum.

**What's needed:** BRD addition: brief positioning statement (2-3 sentences) calibrated to corporate strategy. Examples:
- "Differentiation through member-trust UX in verification" → drives BLOCKERs in U-001, U-002, U-007
- "Differentiation through partner onboarding velocity" → drives BR-802, partner config UX, BAA velocity
- "Differentiation through HIPAA attestation maturity" → drives Phase 4 priority, attestation roadmap
- "Cost leadership at ACO scale" → drives capacity model, cost engineering

Note: positioning doesn't have to mean "uniquely better than everyone" — for a HIPAA platform, "credibly competitive" may be the goal, with differentiation in selected dimensions only.

**Effort:** S (statement); informs roadmap.

---

### E-005: Strategic optionality assessment missing — FINDING

**Where:** Implicit.

**Why it matters:** Decisions today either create or constrain future strategic moves. Examples:
- Single-region commitment (AD-017) constrains partner geographic expansion if a partner requires regional compliance.
- GCP-native commitment (Tech_Stack) constrains M&A integration with non-GCP partners.
- Manual review queue (BR-105) creates option for future ML-augmented review (a competitive move).
- Tokenization abstraction (AD-008) preserves option to swap to Skyflow / self-hosted Vault.

Without explicit optionality assessment, executives can't tell which decisions preserve strategic flexibility.

**What's needed:** ADR or BRD addition: per-major-decision optionality statement. What does this decision foreclose? What does it preserve? At what cost?

**Effort:** S (one paragraph per major decision).

---

## 2. Risk Concentration and Continuity

Engineering identifies risks within their domain. Executives own risk concentration across domains.

### E-006: Vendor concentration risk unflagged — BLOCKER

**Where:** BRD/ARD are GCP-native: AlloyDB, Cloud Run, Cloud SQL, Cloud KMS, BigQuery, Cloud Composer, Cloud Logging, Cloud Monitoring, Pub/Sub, Datastream, Dataflow, Cloud Storage, Cloud Armor, Cloud DNS, Workload Identity, IAM, VPC-SC. Single vendor across the entire technology stack.

**Why it matters:** This is a deliberate decision (GCP-native is strategic per Tech_Stack). It's also a strategic single-point-of-failure for an ACO with HIPAA exposure. Risks:
- GCP pricing changes affect run-rate materially.
- BAA terms change unilaterally (rare but possible).
- Service deprecation timelines (Composer 1 → 2, etc.) force migration on Google's schedule.
- Outage of a critical GCP service (rare but real — see GCP networking incidents 2019, 2020) impacts the entire platform.
- Geopolitical or M&A actions affecting Google could shift the relationship.

For a board-level risk register, vendor concentration risk requires explicit acknowledgment with mitigation strategy (or explicit acceptance of the residual risk).

**What's needed:** Risk register entry (could live in BRD, ADR, or a dedicated risk doc):
- **Risk**: GCP single-vendor concentration
- **Likelihood**: Low for catastrophic; Moderate for material adverse changes
- **Impact**: Existential if catastrophic; significant if adverse
- **Mitigation**: Multi-cloud abstraction in TokenizationService (already partial); periodic vendor health review; BAA renewal calendar; alternative vendor evaluation (annual)
- **Acceptance**: Board-level acknowledgment of residual risk

**Effort:** S (entry); ongoing review.

---

### E-007: Single-region commitment unflagged as strategic risk — FINDING

**Where:** AD-017 commits to us-central1 with multi-AZ; cross-region DR via backup replication.

**Why it matters:** Round 1 F-005 raised this as a DR concern. Strategic concern: regional outages happen (rare but real). Cross-region DR with 4-hour RTO and 15-minute RPO is the engineering target; the *business impact* of 4 hours of Verification outage is not assessed.
- Account creation in Lore application is hard-blocked during outage.
- Member onboarding pipeline halts.
- Partner-facing data freshness degrades.
- Reputation impact of a multi-hour HIPAA-platform outage.

**What's needed:** Business impact assessment for the multi-region decision. If acceptable, document acceptance. If not, multi-region active-active is a significant cost; surface the cost-benefit explicitly.

**Effort:** S (assessment); informs ADR.

---

### E-008: Existential risks not surfaced to board level — BLOCKER

**Where:** BRD has many rules; no risk register at the level of "things that could end the company."

**Why it matters:** Some risks are operational (Datastream lag); some are existential (uncovered HIPAA breach affecting all members; loss of every major partner contract; CMS termination of ACO status). Existential risks need board visibility, executive ownership, and explicit mitigation strategies — not engineering-level controls alone.

**What's needed:** Risk register at executive level:

| Risk | Likelihood | Impact | Owner | Mitigation | Residual |
|---|---|---|---|---|---|
| Uncovered HIPAA breach affecting >100k members | Low | Existential | CISO + CEO | All Round 3 + Round 4 BLOCKERs addressed | Acceptable post-mitigation |
| Loss of major partner contract | Moderate | Material | COO | Partner relationship management; SLA performance | Acceptable |
| CMS termination of ACO status | Very low | Existential | CEO | 42 CFR Part 425 compliance; CMS audit readiness | Acceptable |
| State AG enforcement action | Low | Material | Privacy Officer + CEO | All Round 4 BLOCKERs addressed | Acceptable |
| Vendor concentration failure | Very low | Existential | CTO | E-006 mitigation | Acceptable |
| Insider threat (PII Handler abuse) | Low | Material | CISO | Round 3 S-011, S-036 | Acceptable |
| Class action lawsuit | Moderate | Material | General Counsel + CEO | Round 4 L-058 | Acceptable |
| Catastrophic data loss (no restore) | Very low | Existential | CTO | Round 5 D-039, D-043 | Acceptable post-mitigation |

This register lives outside the BRD/ARD per the user's instruction (it's a business document) but is referenced from the BRD's strategic-context section.

**Effort:** M (executive engagement); ongoing.

---

### E-009: Business continuity vs. disaster recovery distinction missing — BLOCKER

**Where:** BRD/ARD address DR (technical). Business continuity is broader.

**Why it matters:** DR = technical recovery. Business continuity = business operations continuing during stress. Stress events that don't necessarily involve data loss:
- PR crisis (e.g., HIPAA finding becomes public)
- Regulatory action (HHS OCR investigation)
- Partner exit (large partner terminates)
- Key personnel departure (CISO, Privacy Officer, lead engineer)
- Public health emergency (pandemic-style)
- Geopolitical action affecting Sequelae PH
- Cyber attack (ransomware, supply chain)
- Litigation discovery overload

For each: how do operations continue? Who's in charge? What's the communication plan? What's the customer-facing message?

**What's needed:** Business Continuity Plan referenced from BRD (lives elsewhere per the instruction). The BRD reference indicates this exists and is maintained. Plan covers continuity scenarios beyond technical DR.

**Effort:** L (executive + cross-functional); ongoing.

---

### E-010: Reputation defense playbook unaddressed — FINDING

**Where:** Round 4 covered legal procedures for breach notification. Reputation defense is broader.

**Why it matters:** When (not if) the first HIPAA finding occurs:
- Internal communication (workforce, board, investors) — what's the cadence and content?
- External communication (members, partners, regulators, media) — what's the message?
- Spokesperson designation — who speaks, who doesn't?
- Operational continuity during media attention — engineering team focus protected?
- Customer support surge planning — call volume spike during a public incident
- Partner re-confirmation — partners may want fresh attestation post-incident
- Insurance coordination

**What's needed:** Reputation defense playbook (lives outside BRD per instruction). BRD references its existence.

**Effort:** M (executive + comms); ongoing.

---

### E-011: M&A readiness not addressed — FINDING

**Where:** Implicit.

**Why it matters:** Healthcare consolidation is rampant. Three M&A scenarios:
- **Lore acquires another ACO**: data integration, schema reconciliation, member overlap, partner contract assumption. The eligibility platform is the data foundation for this.
- **Lore is acquired**: data portability for due diligence, post-close integration, brand/system consolidation.
- **Lore divests** (less likely but possible): data extraction, partner contract reassignment, member notification.

Each has technical readiness implications. M&A due diligence specifically asks: "Show me your data architecture, your data lineage, your audit log integrity, your partner contract terms, your subprocessor BAA chain, your DR test history, your security incident history."

**What's needed:** M&A readiness assessment as part of strategic context. BRD/ARD architecture should support data extraction at minimum (Round 1 F-006 unmerge is a partial proxy for data portability).

**Effort:** S (assessment); informs roadmap.

---

## 3. Commercial / Revenue Implications

The platform exists in a commercial context that the BRD doesn't connect to.

### E-012: Phased delivery is engineering-phased, not revenue-phased — BLOCKER

**Where:** ARD §"Phased Delivery" defines Phases 0-4 by technical capability.

**Why it matters:** Engineering phases are necessary; revenue phases are different. When does the platform start generating revenue? Phase 1 = single partner end-to-end. Is that sufficient for revenue? For attestation? For onboarding member 1? Engineering phases drive time-to-deliver; revenue phases drive time-to-value.

Today the implicit assumption: revenue starts after Phase 2 (production cutover with all v1 BRs). That may be 6-12 months of build before any revenue. Investors and board may have different expectations.

**What's needed:** Mapping from engineering phases to revenue milestones. Examples:
- Engineering Phase 1 (single-partner end-to-end) → Revenue Phase A: pilot partner; non-paid or paid-pilot; member onboarding begins
- Engineering Phase 2 (production cutover) → Revenue Phase B: paid partner; full member onboarding; partner SLA in effect
- Engineering Phase 3 (scale) → Revenue Phase C: 5-10 partners paying; full attribution captured
- Engineering Phase 4 (hardening) → Revenue Phase D: attestation-required partners onboarded

This mapping does not require creating a strategy document; it can live in BRD's Phased Delivery section as a 1-page addition.

**Effort:** S (mapping); reviewed quarterly.

---

### E-013: Customer acquisition cost (CAC) implications of UX choices unaddressed — FINDING

**Where:** Round 6 raised UX concerns. CAC implications missing.

**Why it matters:** Verification UX is in the critical path of member onboarding. Failure modes (NOT_VERIFIED, lockout, friction challenge) directly affect onboarding conversion. A 1% drop in conversion = N members not onboarded = lost revenue + wasted CAC.

For executives, this means UX choices have CAC implications. Round 6's BLOCKERs (U-001, U-002 specifically) carry commercial weight beyond engineering.

**What's needed:** CAC sensitivity analysis: what's the conversion impact of each major UX choice? Drives prioritization. Lives outside BRD (in business analysis docs); BRD references the analysis.

**Effort:** S (analysis); informs prioritization.

---

### E-014: Customer lifetime value (CLV) implications of trust failures unaddressed — FINDING

**Where:** Round 6 raised member trust; CLV not connected.

**Why it matters:** Trust failures churn members. HIPAA breach, major outage, support failures — each erodes CLV. ACO economics depend on member retention (shared savings accumulates over time per attributed member-year).

**What's needed:** CLV sensitivity analysis: trust events vs. retention. Lives outside BRD; referenced.

**Effort:** S.

---

### E-015: Verification API SLA commitment to Lore application — BLOCKER

**Where:** ARD: "Verification API serves the Lore application's account creation flow." No SLA between teams.

**Why it matters:** This is a commercial commitment between two internal teams (eligibility platform team; Lore application team). If Verification API is at 99.9% (BR-405), that's a commitment. If it ever drops below 99.9%, who is accountable to the Lore application team? What's the remedy?

For external partners receiving this same SLA (verification on their members), the commitment is contractual. Today it's neither.

**What's needed:** Internal SLA agreement (Operational Level Agreement, OLA) between eligibility platform team and Lore application team. Documents:
- Service level commitments (matching BR-404, BR-405)
- Reporting cadence
- Escalation procedures
- Joint incident response
- Breach-of-SLA remedy (no money changes hands internally; remediation, prioritization)

Lives outside BRD per the instruction. BRD references its existence.

**Effort:** S (OLA template); periodic renewal.

---

### E-016: Partner SLA commitments not unified — FINDING

**Where:** BRD/ARD don't specify partner-facing SLA. Each partner contract presumably has its own.

**Why it matters:** If different partners have different SLAs, engineering can't optimize for "the SLA" — there are several. Standardization is a commercial decision (gives partners predictability; gives Lore operational simplicity); customization is competitive flexibility (lets sales tier deal with partner ask).

**What's needed:** Standard partner SLA template. Partner-specific deviations require approval. Lives outside BRD; BRD references.

**Effort:** S (template); ongoing per partner.

---

### E-017: Partnership tiering / strategic partner designation missing — FINDING

**Where:** BRD treats all partners equivalently. No tiering.

**Why it matters:** Some partners are strategic (CMS as a pseudo-partner via the ACO program; large self-insured employers; major payers). Some are peripheral (smaller plans; pilot partners). Resource allocation, feature prioritization, support priority should reflect tier.

**What's needed:** Partner tier framework: criteria for tier assignment, implications per tier (account team, support priority, custom features, data quality thresholds, reconciliation cadence). Lives outside BRD; BRD references.

**Effort:** S.

---

### E-018: Data product strategy unaddressed — FINDING

**Where:** BRD treats eligibility data as a verification source of truth. Analytical use cases mentioned but not strategically positioned.

**Why it matters:** Eligibility data has analytical value beyond verification:
- For Lore: ML feature engineering for clinical product (risk stratification, intervention targeting, outcome prediction)
- For partners: cross-partner population insights, benchmark analytics
- For Lore + partners: shared savings attribution analytics
- Externally: de-identified research datasets (with appropriate de-identification per Round 4 L-039)

Each has business model implications. Today the BRD silently treats analytical use as internal-only.

**What's needed:** Data product strategy decision: in-scope or out-of-scope for eligibility platform. If in-scope, downstream BRs needed (analytical access controls, de-identification framework, monetization rules). If out-of-scope, document the decision so engineering doesn't speculatively build for it.

**Effort:** S (decision); downstream work depending.

---

### E-019: Data monetization rules absent — ADVISORY

**Where:** Implicit; not addressed.

**Why it matters:** Some ACOs monetize de-identified data. Lore's stance on this is a strategic decision with member trust implications.

**What's needed:** Explicit decision (in or out of scope), counsel-coordinated. If in-scope, member transparency requirements and authorization framework (Round 4 L-002, L-065).

**Effort:** S.

---

### E-020: Pricing and economics per partner — FINDING

**Where:** Not addressed in technical repo (correctly — it's a business doc).

**Why it matters:** Per-partner unit economics affect technical decisions (capacity allocation, feature tier, reconciliation effort). The technical repo should reference the business document where this lives.

**What's needed:** BRD reference to partner pricing/economics doc.

**Effort:** S.

---

## 4. Vendor / Supplier Strategy

Beyond E-006 (concentration), vendor strategy has additional executive concerns.

### E-021: Make-vs-buy decision framework missing — BLOCKER

**Where:** Implicit decisions throughout (e.g., Splink vs. building own match engine; Cloud KMS vs. self-hosted; managed vs. self-managed everywhere).

**Why it matters:** Future decisions are inevitable: should we use Skyflow vs. self-hosted Vault? Should we build a custom workforce platform vs. buy Backstage? Should we use Datadog vs. stay on Cloud Monitoring? Each is a strategic decision with cost, speed, lock-in tradeoffs. Without a framework, decisions are ad-hoc.

**What's needed:** Make-vs-buy framework (lives outside BRD; BRD references). Criteria:
- Strategic differentiator? → build
- Compliance baseline? → buy if mature vendor exists
- Operational excellence? → buy
- Optionality? → buy with exit clause
- Vendor concentration risk? → balance vs. consolidation cost

Recurring application: every quarter, review one significant build/buy candidate.

**Effort:** S (framework); quarterly application.

---

### E-022: Vendor BAA negotiation strategy missing — FINDING

**Where:** Round 4 L-029 covered BAA chain. Negotiation strategy missing.

**Why it matters:** Lore is mostly downstream of GCP BAA (terms set by Google; we accept). For non-GCP vendors (Skyflow, Splunk, PagerDuty, etc.), Lore has leverage as a customer. Negotiation strategy:
- Standard terms for low-risk vendors
- Negotiated terms for high-risk vendors
- Walk-away criteria
- Periodic review (BAA terms, pricing, performance)

**What's needed:** Vendor management framework. Lives outside BRD.

**Effort:** S.

---

### E-023: Reciprocal partnership leverage — ADVISORY

**Where:** Not addressed.

**Why it matters:** Lore as a model BAA partner (compliance maturity, audit cooperation, breach notification reliability) can negotiate better terms with vendors. Visible compliance posture is a sales asset.

**What's needed:** Strategic asset framing of compliance posture. Inform sales and partnerships teams.

**Effort:** S.

---

### E-024: Vendor termination playbooks — FINDING

**Where:** Round 4 L-031 covered BAA termination data return.

**Why it matters:** Vendor termination is messy: data extraction, replacement vendor onboarding, re-execution of BAAs, member notification (if subprocessor visible). Pre-planned playbooks reduce friction.

**What's needed:** Vendor termination playbook per critical vendor category. Lives outside BRD.

**Effort:** M.

---

## 5. Talent and Organization

The technical platform requires a team to build and operate it. The BRD/ARD don't address team.

### E-025: Talent strategy beyond Sequelae PH unaddressed — BLOCKER

**Where:** BRD references Sequelae PH (Lore's offshore engineering arm). No US-side talent plan.

**Why it matters:** Sequelae PH is structural; complement of US-side specialists is missing in the BRD/ARD:
- US Privacy Officer (Round 4 L-036): designated person; on payroll
- US Security Officer (Round 4 L-037): designated person
- CISO or fractional CISO equivalent
- US-side PII Handlers (BR-506): how many, on what team
- US-side Break-Glass Admins
- DevOps lead (Round 5 D-034 on-call rotation needs 4-6 engineers minimum)
- Compliance staff for DSAR / complaints / audits
- Partner success / data ops liaison
- Engineering managers per squad

Each has compensation, hiring criteria, retention implications.

**What's needed:** Talent plan / org chart for the platform team. Lives outside BRD; BRD references its existence and dependencies.

**Effort:** M (HR + executive); ongoing.

---

### E-026: Hiring criteria for sensitive roles — FINDING

**Where:** Round 4 L-040 covered background checks; Round 4 L-038 covered training. Hiring criteria deeper:
- PII Handler: relevant compliance background, demonstrated handling of sensitive data, references
- Privacy Officer: HIPAA experience, ideally JD or compliance certification (CHPC, CHC)
- Security Officer: security certifications (CISSP, CISM)
- Engineering: HIPAA-experienced; healthcare domain familiarity desirable

**What's needed:** Hiring criteria framework. Lives outside BRD (HR doc).

**Effort:** S.

---

### E-027: Compensation calibration for sensitive roles — FINDING

**Where:** Not addressed.

**Why it matters:** Roles handling regulated data + insider threat exposure (PII Handler, Privacy Officer, Security Officer, Break-Glass Admin) need compensation calibrated to retention. Underpaid sensitive roles → turnover → compliance gaps + insider threat increase.

**What's needed:** Comp framework for sensitive roles. HR + Legal coordinated.

**Effort:** S.

---

### E-028: Engineering team structure / squad ownership — FINDING

**Where:** ARD references "Wayfinding squad" owning Verification (AD-002). Other contexts' squad ownership unstated.

**Why it matters:** Each bounded context needs a squad / team owner. Without explicit ownership: orphaned services, inconsistent operational maturity, conflicting priorities.

**What's needed:** Per-context squad ownership designation. Lives in BRD or service catalog (Round 5 D-071).

**Effort:** S.

---

### E-029: Headcount plan vs. roadmap — FINDING

**Where:** Not addressed.

**Why it matters:** Phase 1, Phase 2, Phase 3 each have different headcount needs. Phase 1 is foundation; Phase 3 is scaling; both can't run on the same headcount. Without an explicit headcount plan, hiring is reactive (always behind) or speculative (always over-provisioned).

**What's needed:** Headcount plan per phase. Lives outside BRD; BRD references.

**Effort:** S; HR ownership.

---

### E-030: Insourcing / outsourcing strategy per role — ADVISORY

**Where:** Not addressed.

**Why it matters:** Some roles are core (Privacy Officer, Security Officer, lead architects) — insource. Some are episodic (counsel-engaged work, third-party penetration testing, attestation auditors) — outsource. Some are arguable (DevOps tooling, design system).

**What's needed:** Per-role decision framework: insource, outsource, hybrid. Inform org structure decisions.

**Effort:** S.

---

## 6. Decision Authority and Governance

### E-031: No decision authority is visible in BRD/ARD — BLOCKER

**Where:** Implicit.

**Why it matters:** Who approved the seven-context decomposition? The Sequelae PH boundary? The single-region commitment? The 4-tier match policy? Today: invisible. Tomorrow: who can amend? Without decision authority documentation, every amendment is unclear approval, every dispute is hierarchical re-litigation.

**What's needed:** Per major decision (ARD's AD-001 through AD-018; major BRs):
- **Approver**: who approved this (CEO / CTO / CISO / Privacy Officer / Engineering Lead)
- **Approval date**: when
- **Amendment authority**: who can change this (single-approver vs. multi-approver decisions)

Lives in ADR header (per ADR-template.md from Phase 00). Apply consistently. Backfill for AD-001..18.

**Effort:** S.

---

### E-032: Architecture review board (ARB) absent — FINDING

**Where:** Not addressed.

**Why it matters:** Material amendments (cross-context, cross-cutting, regulatory-impacting) need governance review. ARB structure: who's on it, how often, what's escalated.

**What's needed:** ARB charter. Lives outside BRD; BRD references its existence and trigger criteria.

**Effort:** S (charter); ongoing operation.

---

### E-033: Escalation paths for amendments — FINDING

**Where:** CLAUDE.md Rule 12 covers PR merge gate (engineering decision). No escalation for higher-level decisions.

**Why it matters:** Some decisions are engineering-level (PR merge); some are architectural (ARB); some are executive (CEO + CTO + CISO); some are board-level (existential or material).

**What's needed:** Decision tier framework. Per tier, who's the approver, what's the escalation. Lives outside BRD; BRD references.

**Effort:** S.

---

### E-034: BRD/ARD amendment process — FINDING

**Where:** ARD §"Closing Note": "Architectural decisions enumerated here may be revisited only by amendment with the same rigor that produced them."

**Why it matters:** "Same rigor" is undefined. What's the process? Counsel review? ARB review? Board notification? Without process, amendments either stall (over-process) or slip (under-process).

**What's needed:** Amendment process per amendment tier. Lives in BRD/ARD or referenced governance doc.

**Effort:** S.

---

## 7. Reporting and Accountability

### E-035: Executive dashboard / reporting cadence — BLOCKER

**Where:** Not addressed.

**Why it matters:** Executives need visibility into platform health. Today: ad-hoc. Standard:
- Monthly: SLO compliance, security posture, compliance status, key incidents, cost trajectory
- Quarterly: roadmap progress, OKR alignment, partner satisfaction, attestation status
- Annual: comprehensive risk assessment (Round 4 L-049), strategic review

Without cadenced reporting, executives don't know about issues until they're crises.

**What's needed:** Executive reporting framework. Lives outside BRD; BRD references.

**Effort:** M (initial); ongoing.

---

### E-036: Board reporting structure — FINDING

**Where:** Not addressed.

**Why it matters:** Board fiduciary oversight requires visibility. Board reporting:
- Quarterly: high-level platform performance, material risks, regulatory engagement
- Ad-hoc: existential incidents (HIPAA breach, partner exit, regulatory action)

**What's needed:** Board reporting framework. Lives outside BRD.

**Effort:** S.

---

### E-037: Quarterly business review (QBR) of platform — FINDING

**Where:** Not addressed.

**Why it matters:** QBR is the regular executive review touchpoint. Without QBR cadence, platform performance is invisible.

**What's needed:** QBR template, cadence, attendees, agenda. Lives outside BRD.

**Effort:** S.

---

### E-038: KPIs at platform level — BLOCKER

**Where:** BRD has many config parameters and SLO-equivalents (BR-404, BR-405). No headline KPIs.

**Why it matters:** Headline KPIs are the executive shorthand for platform health:
- **Members successfully verified per month** (volume KPI)
- **Verification success rate** (quality KPI; tied to SLO)
- **Median time-to-verify** (UX KPI)
- **Partner contracts active** (commercial KPI)
- **HIPAA incidents** (compliance KPI)
- **Total cost of ownership trajectory** (financial KPI)
- **Mean time to detect breach** (security KPI; Round 4 L-016)
- **Member trust score / NPS** (when available)

**What's needed:** Platform KPI dashboard. Lives outside BRD; BRD references the KPI catalog.

**Effort:** M (catalog); ongoing measurement.

---

### E-039: OKR alignment cadence — FINDING

**Where:** Not addressed.

**Why it matters:** Quarterly OKRs drive priorities. Platform deliverables should map to OKRs. Without mapping, engineering and corporate priorities drift.

**What's needed:** OKR-to-platform mapping per quarter. Lives outside BRD.

**Effort:** S; quarterly.

---

### E-040: Cost variance accountability — FINDING

**Where:** Round 5 D-031 covered cost monitoring; accountability missing.

**Why it matters:** When cost variance occurs (10x normal AlloyDB bill), who explains it? Without accountability, cost overruns are blame-distributed and unresolved.

**What's needed:** Per-cost-driver accountability matrix. Lives outside BRD.

**Effort:** S.

---

### E-041: Unit economics per partner — FINDING

**Where:** Not addressed.

**Why it matters:** Per-partner cost (compute, storage, support, partner ops) vs. per-partner revenue determines partnership viability. Without unit economics, unprofitable partners persist.

**What's needed:** Unit economics framework. Lives outside BRD.

**Effort:** S.

---

## 8. Specific Business Rule Revisits

The user explicitly asked for revisiting business rules. Below is a sample of rules with executive-lens observations. Not exhaustive; representative.

### E-042: BR-101 (Tiered Match Decision) — competitive implications — FINDING

**Where:** BR-101 specifies four-tier match policy.

**Executive observation:** Tier 3 (manual review) is competitive differentiation if executed well (member trust, accuracy); operational liability if executed poorly (reviewer burnout, decision quality, cost). Tier 1-2-4 are industry-standard. The strategic asymmetry: differentiated value lies in Tier 3 quality; that's where investment yields return.

**Implication:** Rate Tier 3 quality (calibration tests, second-reviewer programs, fatigue mitigation per Round 6 U-020) higher than Tier 1 deterministic optimization. Round 6 BLOCKERs U-017 and U-020 deserve executive priority.

---

### E-043: BR-205 (Attribution Neutrality) — business model implication — FINDING

**Where:** BR-205: data product is attribution-neutral; finance reads from it.

**Executive observation:** This is a business model decision baked into architecture. Specifically: the data product does not embed attribution rules, which means attribution rules can change without rebuilding the data product. That preserves option value (good) but may surprise stakeholders who expect "primary partner" to exist (Lore application, finance team).

**Implication:** Validate with Lore application and finance leadership that the attribution-neutral approach matches their expectations. If not, addressing now is cheaper than addressing later.

---

### E-044: BR-401 (External State Set) — UX commercial implication — BLOCKER

**Where:** BR-401: external response set is exactly `{VERIFIED, NOT_VERIFIED}`.

**Executive observation:** This is an explicit privacy-preserving choice. It also forces all member-facing failure UX into the Lore application. Round 6 U-001 and U-002 raised the consequences. The commercial cost of poor failure UX is CAC + brand. The choice (privacy collapse) is right; the *follow-through* (helping the Lore application succeed at the failure UX) is missing.

**Implication:** Internal SLA / commitment between eligibility platform team and Lore application team to jointly own the failure UX (per E-015). Lore application team can't write good failure UX without internal-state hints; platform can't safely give those externally. The internal coordination is the answer.

---

### E-045: BR-402 (Brute Force / Lockout) — UX and CAC implication — FINDING

**Where:** BR-402: 3-tier progressive friction; lockout out-of-band only.

**Executive observation:** "Out-of-band only" recovery is privacy-preserving (no self-service that could be exploited) but commercial-cost-heavy (every locked-out member is a support ticket; some are CAC losses if they don't return). Industry data: 30-50% of locked-out users in healthcare onboarding never return.

**Implication:** Quantify the expected lockout rate, the CAC loss, the support cost. Decision: accept (current rule), reduce (lower lockout threshold, more friction earlier), or invest in better out-of-band (faster human response, asynchronous channels). Business decision.

---

### E-046: BR-506 (Sequelae PH PII Boundary) — strategic posture — FINDING

**Where:** BR-506: Sequelae PH personnel handle tokenized surfaces only.

**Executive observation:** This is a structural business decision (cross-border operations under HIPAA constraint). It has strategic implications: limits Sequelae PH role scope; affects hiring economics; constrains some ML / data engineering work.

**Implication:** Validate with Sequelae PH leadership that scope is correctly understood and accepted. Document the strategic intent (cost-effective offshore engineering with privacy boundary) so future amendments respect the strategic basis.

---

### E-047: BR-705 (Deletion Ledger) — strategic optionality — ADVISORY

**Where:** BR-703: one-way hashed deletion ledger to suppress re-introduction.

**Executive observation:** This rule preserves member trust (deletions are permanent). It also constrains some future moves (M&A integration with another ACO whose data may include previously-deleted members of Lore — those members' suppression must be honored across the merged entity). Strategic constraint that's worth surfacing.

**Implication:** M&A integration playbook should explicitly address deletion ledger reconciliation.

---

### E-048: NFRs as commercial commitments — BLOCKER

**Where:** BRD §"Non-Functional Requirements" specifies latency, availability, freshness, durability, scalability, security, operational efficiency targets.

**Executive observation:** Some of these are commercial commitments (Verification API 99.9%, 200ms p95 — these become partner SLAs and Lore application OLAs). Others are operational (replay capability, idempotent reprocessing). The BRD doesn't distinguish.

**Implication:** Designate NFRs as either:
- **Commercial NFR**: contractually committed to external party (partner SLA, member-facing commitment)
- **Internal NFR**: operational target without external commitment

The distinction matters: commercial NFRs have remediation obligations (financial, contractual) on breach; internal NFRs have engineering obligations only.

**Effort:** S (designation per NFR).

---

### E-049: Configuration parameters as strategic levers — FINDING

**Where:** BRD has 14+ configurable parameters.

**Executive observation:** Some parameters are operational tuning (PROFILE_DRIFT_THRESHOLD); some are strategic (GRACE_PERIOD_DAYS — affects member experience and revenue; FEED_QUARANTINE_THRESHOLD_PCT — affects partner relationship). Strategic parameters need stewarding (who can change, with whose approval).

**Implication:** Per-parameter authority. Strategic parameters require executive sign-off on changes. Operational parameters can be team-level.

**Effort:** S (designation).

---

### E-050: Open Questions as risk register entries — FINDING

**Where:** ARD §"Open Architectural Questions" lists six questions.

**Executive observation:** Each question is a deferred decision. Some have material business consequences if the unfavorable answer surfaces (e.g., "What partners are in scope" — if answer requires architectural change, late). Each question should have:
- **Decision deadline**: by which phase
- **Impact if unfavorable answer**: rebuild scope, contract impact, etc.
- **Owner**: who's chasing the answer

Round 1 F-020 raised this as a finding. From the executive lens, this rises to BLOCKER for the questions with existential impact.

**What's needed:** Risk-register treatment of open questions with deadlines and owners.

**Effort:** S.

---

## 9. Future-State and Exit Strategy

### E-051: Exit strategy per partnership — FINDING

**Where:** BR-801 covers onboarding gates. Off-boarding not addressed.

**Why it matters:** Partnerships end (contract expiration, partner choice, performance issues). Off-boarding involves: data return / destruction, BAA termination, partner notification to members, technical wind-down. Without an off-boarding playbook, exit is messy and risk-prone.

**What's needed:** Partner off-boarding playbook. Lives outside BRD; BRD references.

**Effort:** S.

---

### E-052: Public profile / thought leadership — ADVISORY

**Where:** Implicit.

**Why it matters:** Lore as a HIPAA-mature ACO can establish thought leadership: conference talks, publications, blog posts. Strategic asset for sales and recruiting. Architecture should be defensible publicly.

**What's needed:** Public-profile readiness assessment. Marketing/communications-led.

**Effort:** S.

---

### E-053: Insurance posture — FINDING

**Where:** Round 4 L-054, L-055, L-056 covered insurance categories. Coverage levels and posture missing at the executive lens.

**Why it matters:** Insurance is risk transfer. Coverage limits, exclusions, deductibles, carrier selection — all executive decisions. Periodic review against actual risk landscape.

**What's needed:** Insurance posture document. Lives outside BRD.

**Effort:** S; annual review.

---

### E-054: Strategic technology refresh cadence — ADVISORY

**Where:** Implicit.

**Why it matters:** Technologies age. Splink (current choice) may be eclipsed; AlloyDB (current choice) may have a better successor; tokenization standards evolve. Refresh decisions need cadence.

**What's needed:** Annual technology review; strategic refresh decisions framed at executive level.

**Effort:** S; annual.

---

### E-055: Innovation / R&D budget allocation — ADVISORY

**Where:** Not addressed.

**Why it matters:** Beyond running the platform, what's the budget for innovation (e.g., better identity resolution, ML enhancements, novel UX research)? Without explicit allocation, innovation is the residual after firefighting.

**What's needed:** Innovation budget framework. Lives outside BRD.

**Effort:** S.

---

## 10. Cross-Functional Alignment

### E-056: Cross-functional ownership of the BRD — BLOCKER

**Where:** The BRD authoring is implicitly engineering-led.

**Why it matters:** The BRD/ARD touch Engineering, Compliance, Legal, Operations, Customer Success, Sales, Privacy/Security Officers, Data Owners. Engineering-only authorship misses non-engineering perspectives and undercuts adoption.

**What's needed:** Cross-functional review of BRD/ARD before final ratification. Identify owners per domain (Engineering-led; Compliance review; Legal review; Operations review; CS/Sales review). Ratify with multi-domain sign-off.

**Effort:** M (cross-functional engagement); per amendment.

---

### E-057: Engineering / Compliance / Legal alignment cadence — FINDING

**Where:** Implicit.

**Why it matters:** Compliance (Round 4 BLOCKERs), Legal (Round 4 counsel-engaged items), Engineering (rounds 1-3, 5) all touch the platform. Cross-functional alignment cadence prevents drift.

**What's needed:** Tri-functional alignment meeting cadence. Lives outside BRD.

**Effort:** S.

---

### E-058: Customer Success / Operations interface with platform — FINDING

**Where:** Not addressed.

**Why it matters:** CS / Ops handle members and partners post-onboarding. Their needs from the platform (visibility into a member's eligibility status; handling partner escalations; providing support context) shape engineering requirements that aren't currently captured.

**What's needed:** CS / Ops requirements gathering. Lives outside BRD; surfaces as BR amendments.

**Effort:** S; ongoing.

---

### E-059: Sales engagement on platform capabilities — ADVISORY

**Where:** Not addressed.

**Why it matters:** Sales pitches platform capabilities to prospective partners. Misaligned sales / engineering = sales over-promises, engineering can't deliver.

**What's needed:** Sales / engineering alignment cadence; capability one-pager for sales use.

**Effort:** S.

---

## 11. Strategic Risk Acceptance

### E-060: Documented risk acceptance for residual risks — BLOCKER

**Where:** Round 4 framework (advisories, deferred items) is engineering-level. Executive risk acceptance is missing.

**Why it matters:** Some residual risks are engineering-acceptable but executive-not-acceptable (or vice versa). Documented executive acceptance:
- Names the risk
- States the decision-maker
- States the acceptance basis
- States the review trigger

This protects against future "no one knew this was a risk" claims.

**What's needed:** Executive risk acceptance log. Cross-references the risk register (E-008). Lives outside BRD; BRD references.

**Effort:** S.

---

### E-061: Phase progression authority — FINDING

**Where:** Phase exit criteria are technical. Phase progression authority not specified.

**Why it matters:** Who declares Phase 1 complete and authorizes Phase 2 to begin? This is more than engineering sign-off; it has resource allocation, partner commitment, and risk implications.

**What's needed:** Phase progression authority — likely CTO + CISO + Privacy Officer for transitions; CEO awareness for Phase 2+ (revenue-impacting). Lives in governance doc.

**Effort:** S.

---

### E-062: Material change notification to investors / board — FINDING

**Where:** Not addressed.

**Why it matters:** Material changes (architecture deviation, regulatory action, vendor concentration shift) may require investor / board notification per fiduciary obligations.

**What's needed:** Notification triggers and process. Lives outside BRD.

**Effort:** S.

---

## 12. Specific Strategic Findings

### E-063: Phase 0 governance load front-loads risk — ADVISORY

**Where:** Phase 0 includes IAM audit, VPC-SC perimeter test, observability, CI/CD, etc. Significant scope before any partner value.

**Executive observation:** Phase 0 takes time. During Phase 0, no member is verified, no partner contract is delivered. The organization is paying salaries and infrastructure with no revenue. This is intentional (foundation matters) but the duration should be visible and challenged.

**Implication:** Quantify Phase 0 duration; shorten where possible without quality compromise; ensure investor / board clarity that Phase 0 is "investment, not delay."

---

### E-064: Phase 4 attestation puts compliance late — FINDING

**Where:** Phase 4 includes "SOC 2 Type II or HITRUST CSF readiness."

**Executive observation:** Some partner contracts require attestation before signing. Phase 4 is the last phase. If partner contracts gate on attestation, Phase 4 timing gates partner-on-boarding capacity. Misaligned with revenue ramp.

**Implication:** Either (a) start attestation prep earlier (parallel with Phase 2/3); (b) accept that attestation-required partners are 9-12 months out; (c) explore partial attestation (some controls evidence early). Counsel-coordinated decision.

---

### E-065: Reference ADR-T2.3 / similar internal references — FINDING

**Where:** ARD references "ADR-T2.3 — JWT Authentication" and other phase-task ADRs internally. These references are stale or non-existent in the current repo.

**Executive observation:** Stale internal references erode document trust. Either link to existing ADRs (per repo state), update references to "TBD" with target ADR ID, or remove the references. Audit for similar throughout.

**Implication:** Document hygiene pass before ratification.

**Effort:** S.

---

### E-066: Strategic context section in BRD — BLOCKER

**Where:** BRD §"Document Purpose" frames the BRD's role technically. No strategic context.

**Why it matters:** Anyone reading the BRD without prior context misses the strategic framing. A 1-page strategic context section at the top:
- What is this platform's role in Lore's strategy?
- What outcomes does it serve?
- Who are the strategic stakeholders?
- What's deferred to other documents (referenced)?

This is the *technical expression of strategic intent* — exactly the user's framing. Not creating new strategic docs; concentrating the relevant strategic framing into the BRD's preamble.

**What's needed:** BRD strategic context section. References upstream strategy docs (which live elsewhere). 1 page max.

**Effort:** S.

---

## Summary triage

| Severity | Count | Examples |
|---|---|---|
| BLOCKER | 16 | Business value per rule (E-001), Strategic tier per rule (E-002), Connection to corporate strategy (E-003), Vendor concentration risk acknowledgment (E-006), Existential risk register (E-008), Business continuity vs DR (E-009), Phased delivery → revenue mapping (E-012), Verification API SLA to Lore application (E-015), Make-vs-buy framework (E-021), Talent strategy (E-025), Decision authority documentation (E-031), Executive reporting cadence (E-035), Platform KPIs (E-038), BR-401 commercial implication (E-044 — UX SLA), NFRs as commercial commitments (E-048), Cross-functional ownership of BRD (E-056), Documented executive risk acceptance (E-060), Strategic context section in BRD (E-066) |
| FINDING | 39 | Competitive positioning, strategic optionality, single-region risk, reputation playbook, M&A readiness, CAC implications of UX, CLV implications, partner SLA template, partnership tiering, data product strategy, partner economics references, vendor BAA negotiation, vendor termination, hiring criteria, comp calibration, squad ownership, headcount plan, ARB, escalation paths, BRD amendment process, board reporting, QBR cadence, OKR alignment, cost variance accountability, unit economics, BR-101 Tier 3 prioritization, BR-205 stakeholder validation, BR-402 lockout commercial cost, BR-506 strategic intent documentation, configuration parameters as strategic levers, open questions risk treatment, exit strategy, insurance posture, eng/compliance/legal cadence, CS/Ops interface, sales engagement, phase progression authority, material change notifications, Phase 4 attestation timing, document hygiene |
| ADVISORY | 11 | Reciprocal partnership leverage, insourcing/outsourcing, public profile, technology refresh cadence, innovation budget, BR-705 deletion ledger M&A constraint, Phase 0 duration framing, plus a few smaller items |
| **Total** | **66** | |

---

## Cross-round summary (all seven rounds)

| Round | Lens | BLOCKERS | FINDINGS | ADVISORIES | Total |
|---|---|---|---|---|---|
| 1 | Principal Architect | 6 | 14 | 5 | 25 |
| 2 | Chief Programmer | 13 | 37 | 10 | 60 |
| 3 | Principal Security | 18 | 47 | 9 | 74 |
| 4 | Compliance / Legal | 22 | 44 | 9 | 75 |
| 5 | Principal DevOps | 18 | 44 | 9 | 71 |
| 6 | Principal UI/UX | 17 | 47 | 11 | 75 |
| 7 | CTO / CEO / Executive | 16 | 39 | 11 | 66 |
| **Combined (with overlap)** | — | **110** | **272** | **64** | **446** |

After de-duplication across all seven rounds: **~95-100 unique BLOCKERs**.

The executive round is smaller in count than security or compliance because executive concerns are largely about *connecting* what other rounds surfaced to business value, ownership, and strategic context. Many executive findings reference prior rounds with "this is BLOCKER from the executive lens because [commercial / strategic / risk reason]." That's the right shape — executives don't duplicate engineering work; they connect engineering to strategy.

---

## What this round specifically owns

What I could surface that prior rounds couldn't:

1. **Business-value framing per rule** (E-001) — connects engineering rules to business outcomes
2. **Strategic tier designation** (E-002) — differentiated value vs. table stakes vs. gold-plating
3. **Connection to corporate strategy** (E-003) — the technical repo references upstream strategic docs
4. **Vendor concentration as board-level risk** (E-006) — cross-domain risk other rounds couldn't surface
5. **Existential risk register** (E-008) — risks that aren't engineering, security, compliance, ops, or UX, but business
6. **Business continuity beyond DR** (E-009) — operations during stress
7. **Engineering-phased vs revenue-phased delivery** (E-012) — when does value generate
8. **Internal SLA / OLA between teams** (E-015) — commercial commitments between internal parties
9. **Make-vs-buy framework** (E-021) — recurring decision template
10. **Talent strategy connecting to platform requirements** (E-025) — who builds and operates this
11. **Decision authority documentation** (E-031) — who approved what; who can amend
12. **Executive reporting cadence** (E-035) — how does the platform talk to leadership
13. **Platform KPIs at executive level** (E-038) — beyond SLOs
14. **NFRs as commercial commitments** (E-048) — distinguishing internal targets from external commitments
15. **Cross-functional ownership of BRD** (E-056) — engineering doesn't own this alone
16. **Strategic context section in BRD** (E-066) — concentrating the strategic framing in the technical artifact without creating a new doc
17. **Specific business rule revisits** (E-042 through E-050) — applying executive lens to existing rules

---

## What this review did NOT cover

Out of scope for executive lens:

- Architectural decomposition (Round 1)
- Code-level discipline (Round 2)
- Security technical controls (Round 3)
- Regulatory mandates (Round 4)
- Operational engineering (Round 5)
- User experience design (Round 6)
- Domain correctness (DE Principal — not yet conducted)
- Authoring of strategic documents themselves (per user's instruction — those live elsewhere)
- Authoring of business documents not in this repo (per user's instruction)

These belong to other reviewers, business documents in other repos, or downstream executive engagement. This round focused on the executive concerns that, if unaddressed, leave the platform technically excellent but strategically rudderless.

---

## Closing

The platform is being built to serve Lore's strategic intent. The technical repo must be the technical expression of that intent — not a duplicate strategic document, but a faithful expression. Today, the BRD/ARD are silent on the strategic framing that makes their rules meaningful. The executive BLOCKERs above ask the platform to express that framing — connecting engineering rules to business value, surfacing decision authority, designating strategic tiers, and acknowledging the cross-functional and board-level concerns that engineering alone cannot bear.
